Clinical Trial: Performance and Impact of the Sepsis ImmunoScore

U.S., April 23 -- ClinicalTrials.gov registry received information related to the study (NCT07543497) titled 'Performance and Impact of the Sepsis ImmunoScore' on Sept. 30, 2025.

Brief Summary: The goal of this prospective cohort device study is to assess clinical usage and impact, diagnostic performance, and prognostic performance of the Sepsis ImmunoScore.

Study Start Date: April, 2026

Study Type: OBSERVATIONAL

Condition: Sepsis

Intervention: DIAGNOSTIC_TEST: Sepsis ImmunoScore

The Sepsis ImmunoScore is a risk stratification tool that uses Artificial Intelligence/Machine Learning to aid in the identification of patients likely to have or progress to sepsis within 24 hours of assessment.

Recruitment Status: NOT_YET_RECRUITING

Spo...